Syneos Health, Inc. (SYNH) Stock Analysis
DELISTED 2023
What happened to Syneos Health, Inc. (SYNH) stock?
Syneos Health, Inc. (SYNH) no longer trades on public markets. It was delisted in September 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- September 2023
- Last recorded price (historical):
- $42.98 (last quote on record before the September 2023 delisting; historical, not a current quote)
P/E 16.72 means the share price is 16.72 times one year of earnings per share. Market cap $4.46B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Syneos Health, Inc. (SYNH). Syneos Health, Inc. is a biopharmaceutical outsourcing solutions company operating in North America, Europe, and Asia-Pacific. They provide clinical and commercial solutions to pharmaceutical, biotechnology, and healthcare industries.
Last analyzed: Mar 16, 2026Syneos Health, Inc. (SYNH) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SYNH shares?
No. SYNH stopped trading on public markets in September 2023, so the shares are not available through a broker. Anything you see quoted for SYNH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SYNH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Syneos Health, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.